Molecular tests versus cytology.

Statistical measures have been calculated using 197 CIN2+, 400 histological confirmed CIN2- and 576 clinically negative cases. Inadequate or invalid molecular testing results have been considered as negative and have not been excluded in order to measure clinical efficiency of the tests in every day conditions.

本研究基于197例宫颈上皮内瘤变2级及以上（CIN2+）、400例经组织学确认的宫颈上皮内瘤变2级阴性（CIN2-）以及576例临床阴性病例，计算得到各项统计指标。为了在日常临床场景中评估该检测方法的实际临床效能，本研究将不合格或无效的分子检测结果归类为阴性，且未将此类结果排除在统计范围之外。